                         SEQUENCE LISTING

<110>  The UAB Research Foundation
 
<120>  UL97 for Treatment of Protein Aggregate Disorders

<130>  20674-066WO1

<150>  US 60/914,911
<151>  2007-04-30

<160>  20    

<170>  PatentIn version 3.3

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sequence Motif


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is any amino acid.

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is any amino acid.

<400>  1

Leu Xaa Cys Xaa Glu 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sequence Motif


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is any amino acid.

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is any amino acid.

<400>  2

Leu Xaa Cys Xaa Asp 
1               5   


<210>  3
<211>  22
<212>  PRT
<213>  Human cytomegalovirus

<400>  3

Ser Gly Asp Gly Tyr His Gly Leu Arg Cys Arg Glu Thr Ser Ala Met 
1               5                   10                  15      


Trp Ser Phe Glu Tyr Asp 
            20          


<210>  4
<211>  22
<212>  PRT
<213>  Chimpanzee cytomegalovirus

<400>  4

Gly Gly Ser Ser Tyr His Gly Leu Arg Cys Arg Glu Ser Ser Asp Met 
1               5                   10                  15      


Trp Ser Phe Glu Tyr Glu 
            20          


<210>  5
<211>  20
<212>  PRT
<213>  Simian virus 40

<400>  5

Asn Ala Phe Asn Glu Glu Asn Leu Phe Cys Ser Glu Glu Met Pro Ser 
1               5                   10                  15      


Ser Asp Asp Glu 
            20  


<210>  6
<211>  19
<212>  PRT
<213>  Human adenovirus 52

<400>  6

Arg Gly Glu Glu Leu Asp Lys Cys Tyr Glu Glu Cys Leu Pro Ser Ser 
1               5                   10                  15      


Asp Ser Glu 
            


<210>  7
<211>  20
<212>  PRT
<213>  Human papillomavirus

<400>  7

Gln Pro Glu Thr Thr Asp Leu Tyr Cys Tyr Glu Gln Leu Asn Asp Ser 
1               5                   10                  15      


Ser Glu Glu Glu 
            20  


<210>  8
<211>  33
<212>  PRT
<213>  Human herpesvirus 6A

<400>  8

Asp Cys Ser Ala Ile Glu Glu Leu Leu Cys His Glu Ser Leu Leu Asp 
1               5                   10                  15      


Ser Pro Met Lys Leu Ser Asn Ala His Thr Met Phe Ser Ser Asp Lys 
            20                  25                  30          


Trp 
    


<210>  9
<211>  33
<212>  PRT
<213>  Human herpesvirus 6B

<400>  9

Asp Cys Ser Ala Ile Glu Glu Leu Leu Cys His Glu Ser Leu Leu Asp 
1               5                   10                  15      


Ser Pro Met Lys Leu Ser Asn Ala His Thr Ile Phe Ser Ser Asn Lys 
            20                  25                  30          


Trp 
    


<210>  10
<211>  33
<212>  PRT
<213>  Human herpesvirus 7

<400>  10

Pro Asp Pro Ser Val Thr Asp Leu Leu Cys His Glu Ser Leu Thr Val 
1               5                   10                  15      


Ser Pro Lys Phe Glu Arg Asp Gly Leu Ser Ala Cys Thr Glu Phe Glu 
            20                  25                  30          


Asn 
    


<210>  11
<211>  33
<212>  PRT
<213>  Human cytomegalovirus

<400>  11

Leu Val Asp Ala Leu Glu Gln Leu Ala Cys Ser Asp Pro Asn Thr Tyr 
1               5                   10                  15      


Ile His Lys Thr Glu Thr Asp Glu Arg Gly Gln Trp Ile Met Leu Phe 
            20                  25                  30          


Leu 
    


<210>  12
<211>  32
<212>  PRT
<213>  Human cytomegalovirus

<400>  12

His His Asp Gln Trp Lys Leu Ala Cys Ile Asp Ser Tyr Arg Arg Ala 
1               5                   10                  15      


Phe Cys Thr Leu Ala Asp Ala Ile Lys Phe Leu Asn His Gln Cys Arg 
            20                  25                  30          


<210>  13
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DSSE Motif

<400>  13

Asp Ser Ser Glu 
1               


<210>  14
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  14
caccatgtcc tccgcacttc ggtct                                           25


<210>  15
<211>  29
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  15
tcaccttcga ccgcccgtag ctgtcgatg                                       29


<210>  16
<211>  19
<212>  DNA
<213>  Artificial Sequence 

<220>
<223>  Primer

<400>  16
ttactcgggg aacagttgg                                                  19


<210>  17
<211>  29
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  17
agtggaagct ggcgggcatc gacagctac                                       29


<210>  18
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  18
ggtgccgaac gcgccggcgc tttgaag                                         27


<210>  19
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer

<400>  19
ccacggcttg cgcggccgcg aaacttc                                         27


<210>  20
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus Sequence


<220>
<221>  MISC_FEATURE
<223>  X is any amino acid.

<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (5)..(6)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (14)..(26)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (32)..(32)
<223>  Xaa can be any naturally occurring amino acid

<400>  20

Xaa Xaa Asp Ala Xaa Xaa Asp Leu Xaa Cys His Glu Ser Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Met Trp Ser Ser Asp Xaa 
            20                  25                  30          


Glu 
    


